ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 6, 2023 /PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that it has…

Click here to view original post